Literature DB >> 30005357

Limbic encephalitis associated with systemic sclerosis.

Pia De Stefano1, Carlo Chizzolini2, Patrice H Lalive3, Agustina M Lascano3.   

Abstract

We report the case of a patient affected by systemic sclerosis (SSc) who developed autoimmune limbic encephalitis, which improved under immunosuppressant agents and high-dose intravenous immunoglobulins. In our patient the autoimmune encephalitis occurred during apparently quiescent SSc, though concomitantly with novel arthritis. Moreover, our patient showed auto-antibodies directed against SSA antigen but the panel of auto-antibodies associated with autoimmune encephalitis was negative. We discuss the potential for immunopathogenic inflammatory events affecting the central nervous system in SSc then favoring the occurrence of autoimmune encephalitic disorders. The possibility of a "neuro-scleroderma" may have important consequences in terms of therapeutic approaches.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Antibody-negative; Autoimmune encephalitis; Epilepsy; Immunotherapy; Systemic sclerosis

Mesh:

Year:  2018        PMID: 30005357     DOI: 10.1016/j.msard.2018.06.019

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  2 in total

Review 1.  Pathophysiology of cognitive dysfunction and the role of combined brain/heart magnetic resonance imaging (Review).

Authors:  George Markousis-Mavrogenis; Flora Bacopoulou; Genovefa Kolovou; Maria-Roser Pons; Aikaterini Giannakopoulou; Antigoni Papavasiliou; George D Kitas; George P Chrousos; Sophie I Mavrogeni
Journal:  Exp Ther Med       Date:  2022-07-14       Impact factor: 2.751

Review 2.  Cognitive dysfunction in autoimmune rheumatic diseases.

Authors:  Csaba Oláh; Noa Schwartz; Christopher Denton; Zsófia Kardos; Chaim Putterman; Zoltán Szekanecz
Journal:  Arthritis Res Ther       Date:  2020-04-15       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.